A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse.
Yung WK, Albright RE, Olson J, Fredericks R, Fink K, Prados MD, Brada M, Spence A, Hohl RJ, Shapiro W, Glantz M, Greenberg H, Selker RG, Vick NA, Rampling R, Friedman H, Phillips P, Bruner J, Yue N, Osoba D, Zaknoen S, Levin VA.
Yung WK, et al. Among authors: albright re.
Br J Cancer. 2000 Sep;83(5):588-93. doi: 10.1054/bjoc.2000.1316.
Br J Cancer. 2000.
PMID: 10944597
Free PMC article.
Clinical Trial.